Response to: 'Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis' by Wallace et al

Kronbichler Andreas; Kerschbaum Julia

首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Response to: 'Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis' by Wallace et al

【24h】

Response to: 'Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis' by Wallace et al

机译：回应：'利妥昔单抗患者严重感染的风险及抗菌预防效果'由华莱士等人的疗效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research》 |2020年第4期|共2页
作者
Kronbichler Andreas; Kerschbaum Julia;
展开▼
作者单位

Addenbrookes Hosp Vasculitis &

Lupus Clin Cambridge England;

Dept Internal Med IV Nephrol &

Hypertens Anichstr A-6020 Innsbruck Austria;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
infections; epidemiology; treatment; ANCA;

机译：感染;流行病学;治疗;ANCA;
入库时间 2022-08-20 01:25:02

相似文献

外文文献
中文文献
专利

1. Response to: 'Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis' by Wallace et al [J] . Kronbichler Andreas, Kerschbaum Julia Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2020,第4期

机译：回应：'利妥昔单抗患者严重感染的风险及抗菌预防效果'由华莱士等人的疗效
2. Rituximab and eculizumab when treating nonmalignant hematologic disorders: infection risk, immunization recommendations, and antimicrobial prophylaxis needs [J] . Elissa R.Engel, Jolan E.Walter Hematology . 2020,第1期

机译：治疗非开始性血液学疾病时的Rituximab和Eculizumab：感染风险，免疫推荐和抗微生物预防需求
3. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors. [J] . Steinberg JP, Braun BI, Hellinger WC Annals of Surgery . 2009,第1期

机译：抗菌药物预防的时间安排和手术部位感染的风险：减少抗菌药物预防错误的试验结果。
4. Efficacy of Novel Antimicrobial Post-milking Teat Dip on the Rate of New Intramammary Infections with an Experimental Bacterial Challenge Against Contagious Mastitis Organisms [C] . David M. Galton, Leo Timms Annual Meeting of the National Mastitis Council . 2015

机译：新型抗菌乳酸乳酸滴眼液对新患有乳腺炎生物体的实验细菌攻击的新脑内感染率的疗效
5. Antimicrobial Peptides as Dual Therapeutic Strategies to Treat Venezuelan Equine Encephalitis Virus Infections and the Associated Inflammatory Response [D] . Ahmed, Aslaa. 2020

机译：抗微生物肽作为双重治疗策略，治疗委内瑞拉马脑炎病毒感染和相关的炎症反应
6. Rituximab and eculizumab when treating nonmalignant hematologic disorders: infection risk immunization recommendations and antimicrobial prophylaxis needs [O] . Elissa R. Engel, Jolan E. Walter 2020

机译：治疗非开始性血液学疾病时的Rituximab和Eculizumab：感染风险免疫推荐和抗微生物预防需求
7. Response to: ‘Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis’ by Wallace et al [O] . Andreas Kronbichler, Julia Kerschbaum 2019

机译：响应：“利妥昔单抗之后严重感染的风险和抗菌预防”由华莱士等人的疗效

Response to: 'Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis' by Wallace et al

著录项

相似文献

相关主题

期刊订阅